Within the tumor microenvironment, IL-1β acts on endothelial cells, fibroblasts, and immune subsets to promote angiogenesis, recruit immunosuppressive myeloid cells, and sustain chronic inflammation that facilitates tumor progression [4,12,15,16,17]. Here, IL1B is linked to neoplasm.